Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × apatinib × Clear all

Phase

Status

Unknown 7 Withdrawn 1 Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 8 Stomach Neoplasms 5 Liver Neoplasms 3 Cholangiocarcinoma 3 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Nasopharyngeal Carcinoma 2 Esophageal Squamous Cell Carcinoma 2 Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Cancer Limited Stage 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Salivary Gland Neoplasms 1 SCLC 1 Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Malignant Neoplasms of Digestive Organs 1 Locally Advanced Thyroid Gland Carcinoma 1 HER2-negative Breast Cancer Brain Metastases 1 Gastrointestinal Stromal Tumors 1 Fludzoparib" and Anti-angiogenic 1 Digestive System Neoplasms 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Breast Cancer Metastatic 1

Interventions

Doxorubicin 14 pembrolizumab 9 Gemcitabine 8 Surgical Procedures, Operative 7 Nivolumab 6 Blood Specimen Collection 6 Trabectedin 5 Surveys and Questionnaires 5 Ifosfamide 5 Drug Therapy 5 Cyclophosphamide 5 Radiotherapy 4 Radiation Dose Hypofractionation 4 liposomal doxorubicin 3 fludarabine 3 atezolizumab 3 anlotinib 3 Radiation 3 Observation 3 Ipilimumab 3 Docetaxel 3 Biopsy 3 trastuzumab deruxtecan 2 selinexor 2 repotrectinib 2 pazopanib 2 fluzoparib 2 fludarabine phosphate 2 eribulin 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04072042 2025-05-14

BIOVAS

Ruijin Hospital

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡